Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03498651 · ClinicalTrials.gov registry record · Phase 2
Interpretation Training to Reduce Anxiety: Evaluating Technology-based Delivery Models and Methods to Reduce Attrition
A Phase 2 study of Anxiety, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,748
- Enrollment target
- 1
- Study location
NCT03498651: Completed Phase 2 study of Anxiety, sponsored by University of Virginia.
NCT03498651 is a Phase 2 study of Anxiety that has completed, run by University of Virginia. The registered enrollment target is 1,748 participants, above the 435-participant average among 364 other Anxiety trials with a reported enrollment target (302% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03498651, a Phase 2 study of Anxiety, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,748 participants
- Enrollment target
- 1
- Study location
Study Summary
The project aims to compare effectiveness and target engagement of CBM-I delivered via computer vs. mobile phone, and test if adding minimal human contact for participants at risk of dropout improves retention and outcomes.
Primary Outcome
To measure interpretation bias, participants will read ambiguous scenarios with titles, after which they will see the titles of each scenario, followed by 4 interpretations of the scenario: 1 positive and threat related, 1 negative and threat related, 1 positive and threat unrelated, and 1 negative and threat unrelated. Participants will rate each interpretation based on how similar in meaning it is to the original scenario on a 4-point scale ranging from 1 to 4. The mean of the positive, threat
Conditions Studied
Interventions
- BEHAVIORAL Coaching
- BEHAVIORAL Cognitive Bias Modification - Interpretation training
- BEHAVIORAL Online psychoeducation about anxiety
Study Locations (1)
Virginia
- MindTrails web site: https://mindtrails.virginia.edu/ (thru Univ. of Virginia) - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,748 participants |
| Start Date | 2019-01-20 |
| Est. Completion | 2020-12-03 |
| Phase | Phase 2 |
What the finished NCT03498651 record still lists
NCT03498651 is an interventional study that assigns participants to a tested intervention. Its 1,748 participants enrollment target places it among the larger protocols in the corpus, above the 435-participant average among 364 other Anxiety trials with a reported enrollment target (302% higher).
The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 3 interventions - of which Coaching is the first listed.
NCT03498651 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03498651 about?
NCT03498651 is a clinical study titled "Interpretation Training to Reduce Anxiety: Evaluating Technology-based Delivery Models and Methods to Reduce Attrition". The project aims to compare effectiveness and target engagement of CBM-I delivered via computer vs. mobile phone, and test if adding minimal human contact for participants at risk of dropout improves retention and outcomes.
What is the current status of trial NCT03498651?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,748 participants. The study started on 2019-01-20. Estimated completion is 2020-12-03.
What conditions does trial NCT03498651 study?
This clinical trial studies the following conditions: Anxiety.
What interventions are being tested in trial NCT03498651?
The interventions under investigation include: Coaching (BEHAVIORAL), Cognitive Bias Modification - Interpretation training (BEHAVIORAL), Online psychoeducation about anxiety (BEHAVIORAL).
Who is sponsoring clinical trial NCT03498651?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03498651 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03498651's enrollment target sits among peer trials
1,748 12th of 364 higher than 353 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Use of CBD in the Treatment of Anxiety
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- NCT06954337 · 1,750 participants · NA
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
- NCT07183527 · 1,750 participants · NA
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
- NCT07062172 · 1,753 participants · NA
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI